SCHEMBL4755798

SCHEMBL4755798

Cc1cccc(C(=O)Nc2ncc(S(C)(=O)=O)s2)c1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 2/20 0.63
KDR P35968 2/20 0.47
MAPT P10636 3/20 0.44
CRHBP P24387 2/20 0.44
CRHR2 Q13324 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
FFAR2 O15552 1/20 0.44
ALDH1A1 P00352 2/20 0.44
GAA P10253 2/20 0.43
GRM4 Q14833 3/20 0.43
PLAU P00749 2/20 0.43
F2 P00734 1/20 0.43
F10 P00742 1/20 0.43
PLG P00747 1/20 0.43
PLAT P00750 1/20 0.43
KLK1 P06870 1/20 0.43
KLK5 Q9Y337 1/20 0.43
P2RX1 P51575 1/20 0.43
NPC1 O15118 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756933 0.89 RAB9A (0.53) STAT3MAPTCRHBPCRHR2MEN1
SCHEMBL4756542 0.87 STAT3 (0.47) STAT3KDRMAPTCRHBPCRHR2
SCHEMBL4756965 0.87 FFAR2 (0.48) STAT3MAPTCRHBPCRHR2MEN1
SCHEMBL4755831 0.86 STAT3 (0.47) STAT3MAPTCRHBPCRHR2MEN1
SCHEMBL4755842 0.86 STAT3 (0.47) STAT3KDRMAPTCRHBPCRHR2
SCHEMBL4756867 0.85 STAT3 (0.46) STAT3MAPTCRHBPCRHR2MEN1
SCHEMBL10113734 0.85 KLKB1 (0.48) STAT3MAPTCRHBPCRHR2MEN1
SCHEMBL31426452 0.84 STAT3 (0.58) STAT3MAPTCRHBPCRHR2MEN1
SCHEMBL704075 0.84 STAT3 (0.58) STAT3MAPTCRHBPCRHR2MEN1
SCHEMBL4755812 0.83 ALDH1A1 (0.46) STAT3MAPTCRHBPCRHR2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC STAT3 63/4885KDR 4456/4885MAPT 4288/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC STAT3 63/4885KDR 4456/4885MAPT 4288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.